KIMBERLEY SORRELL: Open Payments
NPI 1780183228 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 44 payments from 11 companies in 2025. Trend: 2023 $1,136 · 2024 $1,723 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $177 |
| ABBVIE INC. | 9 | $139 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Abbott Laboratories | 4 | $88 |
| Lilly USA, LLC | 3 | $82 |
| Amgen Inc. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| PFIZER INC. | 1 | $18 |
Products named: Wegovy, VRAYLAR, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, MOUNJARO, Kerendia, EVENITY, QULIPTA.
Industry payments across VA — which companies pay providers there.
